Page 1 of Clinical Trials for Mantle Cell Lymphoma, 782 Total Matches
- 1Active, not recruitingLast Updated: February 17, 2012Condition(s): Mantle Cell Lymphoma
- 2TerminatedLast Updated: October 7, 2009Condition(s): Mantle Cell Lymphoma; Lymphoma
- 3RecruitingLast Updated: May 2, 2012Condition(s): Mantle Cell Lymphoma; Relapsed or Refractory Mantle Cell Lymphoma
- 4RecruitingLast Updated: May 17, 2012Condition(s): Solid Tumors or Mantle Cell Lymphoma
- 5Not yet recruitingLast Updated: April 13, 2012Condition(s): Mantle Cell Lymphoma
- 6Active, not recruitingLast Updated: March 9, 2012Condition(s): Lymphoma, Mantle- Cell
- 7Active, not recruitingLast Updated: March 22, 2012Condition(s): Mantle Cell Lymphoma
- 8TerminatedLast Updated: October 25, 2011Condition(s): Follicular Lymphoma; Marginal Zone Lymphoma; Mantle Cell Lymphoma
- 9TerminatedLast Updated: March 3, 2011Condition(s): Mantle Cell Lymphoma
- 10RecruitingLast Updated: November 18, 2011Condition(s): Mantle Cell Lymphoma
- 11RecruitingLast Updated: November 10, 2011Condition(s): Mantle Cell Lymphoma
- 12WithdrawnLast Updated: December 4, 2006Condition(s): Contiguous Stage II Mantle Cell Lymphoma; Noncontiguous Stage II Mantle Cell Lymphoma; Stage III Mantle Cell Lymphoma; Stage IV Mantle Cell Lymphoma; Recurrent Mantle Cell Lymphoma
- 13Active, not recruitingLast Updated: May 14, 2009Condition(s): Lymphoma
- 14RecruitingLast Updated: October 27, 2010Condition(s): Mantle Cell Lymphoma
- 15Active, not recruitingLast Updated: June 16, 2010Condition(s): Non-Hodgkin's Lymphoma
- 16CompletedLast Updated: December 26, 2008Condition(s): Mantle Cell Lymphoma
- 17RecruitingLast Updated: May 3, 2012Condition(s): Mantle Cell Lymphoma; Lymphoma
- 18Active, not recruitingLast Updated: June 10, 2011Condition(s): Mantle Cell Lymphoma
- 19Active, not recruitingLast Updated: April 18, 2011Condition(s): Untreated Mantle Cell Lymphoma
- 20Active, not recruitingLast Updated: March 22, 2012Condition(s): Adult Nasal Type Extranodal NK/T-cell Lymphoma; Anaplastic Large Cell Lymphoma; Angioimmunoblastic T-cell Lymphoma; Contiguous Stage II Mantle Cell Lymphoma; Cutaneous B-cell Non-Hodgkin Lymphoma; Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; Nodal Marginal Zone B-cell Lymphoma; Noncontiguous Stage II Mantle Cell Lymphoma; Recurrent Adult Burkitt Lymphoma; Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent Adult Diffuse Mixed Cell Lymphoma; Recurrent Adult Diffuse Small Cleaved Cell Lymphoma; Recurrent Adult Grade III Lymphomatoid Granulomatosis; Recurrent Adult Hodgkin Lymphoma; Recurrent Adult Immunoblastic Large Cell Lymphoma; Recurrent Adult Lymphoblastic Lymphoma; Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Recurrent Mycosis Fungoides/Sezary Syndrome; Recurrent Small Lymphocytic Lymphoma; Splenic Marginal Zone Lymphoma; Stage I Cutaneous T-cell Non-Hodgkin Lymphoma; Stage I Mantle Cell Lymphoma; Stage I Mycosis Fungoides/Sezary Syndrome; Stage II Cutaneous T-cell Non-Hodgkin Lymphoma; Stage II Mycosis Fungoides/Sezary Syndrome; Stage III Cutaneous T-cell Non-Hodgkin Lymphoma; Stage III Mantle Cell Lymphoma; Stage III Mycosis Fungoides/Sezary Syndrome; Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma; Stage IV Mantle Cell Lymphoma; Stage IV Mycosis Fungoides/Sezary Syndrome; Waldenström Macroglobulinemia
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Mantle+Cell+Lymphoma
